Publication | Closed Access

The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer

Cardiovascular ToxicityBreast OncologyOncologyCardiovascular DiseaseMedicinePost-menopausal WomenGynecologyBreast CancerPharmacotherapyAromataseMenopauseAromatase InhibitorsPharmacologyEndocrine-related CancerWomen's HealthMyocardial Infarction